Search Results | Litt's Drug Eruption and Reaction Database

Adverse reactions attributed to entire drug class 'Sodium-glucose co-transporter 2 (SGLT2) inhibitor ('gliflozin')'

Please login to view adverse reactions.

Photosensitivity

(2017): Raschi E+, Nutr Metab Cardiovasc Dis 27(12), 1098

Rash

(2017): Raschi E+, Nutr Metab Cardiovasc Dis 27(12), 1098

Thinning

(2025): Semersky A+, Aesthet Surg J Open Forum Apr (e-Collection)

Ulcerations

(2023): Esteban Jiménez Ó+, Semergen (Spanish) Oct, Online ahead of print (association; Spanish Pharmacovigilance System of Medicines for Human Use database)

Urticaria / hives

(2017): Raschi E+, Nutr Metab Cardiovasc Dis 27(12), 1098

Acute coronary syndrome

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)

Hypotension

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)
(2014): Mikhail N, World J Diabetes 5(6), 854 [REVIEW]

Ventricular dysfunction (left ventricular dysfunction / right ventricular dysfunction)

(2023): Alfaris I+, Can J Cardiol Aug, Online ahead of print

Vertigo / dizziness

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)
(2014): Mikhail N, World J Diabetes 5(6), 854 [REVIEW]

Dehydration

(2017): Trujillo JM+, Pharmacotherapy 37(4), 481

Diabetic ketoacidosis

(2022): Palanca A+, Diabetes Care Jan, Online ahead of print4%
(2021): Zheng C+, Cardiovasc Diabetol 20(1), 83 [REVIEW] (association)
(2019): Nappi F+, Medicina (Kaunas) 55(8), pii:E462 (1 case)
(2019): Shi FH+, Front Pharmacol Sep, 10:1066 [REVIEW]
(2019): Wang CT+, J Formos Med Assoc Dec, Epub ahead of print (1 case)
(2018): Bonora BM+, Diabetes Obes Metab 20(1), 25 [REVIEW]
(2018): Singh M+, Curr Drug Saf Feb, Epub ahead of print [REVIEW]
(2017): Burke KR+, Pharmacotherapy 37(2), 187 [REVIEW]
(2017): Chen J+, Sci Rep 7, Epub [REVIEW]
(2017): Mizuno A+, Rev Med Suisse (French) 13(565), 1164 [REVIEW] (euglycemic)
(2017): Moumouni ANA+, Fundam Clin Pharmacol Nov, Epub ahead of print
(2017): Trujillo JM+, Pharmacotherapy 37(4), 481
(2016): Scheen AJ, Curr Diab Rep 16(10), 92 [REVIEW]

Euglycemic diabetic ketoacidosis

(2021): Somagutta MR+, Cureus 13(3), e13665 [REVIEW]

Fluid depletion / volume depletion

(2021): Rahhal A+, Curr Probl Cardiol Sep, Online ahead of print [REVIEW]

Hyperglycemia (includes glucose increased)

(2019): Wang CT+, J Formos Med Assoc Dec, Epub ahead of print (1 case)

Hypoglycemia

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)
(2019): Shi FH+, Front Pharmacol Sep, 10:1066 [REVIEW]

Nausea

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)

Genital mycotic infection

(2022): Palanca A+, Diabetes Care Jan, Online ahead of print23%
(2022): Tsai WC+, BMJ Open 12(10), e060655 [REVIEW] (increased risk)
(2022): Younes AM+, Int J Cardiol Jun, Online ahead of print [REVIEW]
(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection) 73%
(2019): Shi FH+, Front Pharmacol Sep, 10:1066 [REVIEW]
(2017): Trujillo JM+, Pharmacotherapy 37(4), 481
(2016): Gomez-Fernandez P+, Med Clin (Barc) 147 Suppl 1, 44
(2016): Scheen AJ, Curr Diab Rep 16(10), 92 [REVIEW]
(2015): Scheen AJ, Drugs 75(1), 33
(2014): Halimi S+, Diabetes Metab 40(6 Suppl 1), S28
(2014): Mikhail N, World J Diabetes 5(6), 854 [REVIEW]
(2014): Nauck MA, Drug Des Devel Ther 8, 1335
(2012): Rosak C+, MMW Fortschr Med (German) 154 Suppl 4, 95 [REVIEW]

Genital pruritus

(2016): Sosale B+, J Assoc Physicians India 64(9), 404%

Genitourinary infection / genital infection / reproductive tract infection

(2023): Li CX+, Front Endocrinol (Lausanne) Aug (e-Collection) 5% [REVIEW] (association)

Pollakiuria

(2023): Li CX+, Front Endocrinol (Lausanne) Aug (e-Collection) 3% [REVIEW] (association)

Polyuria (includes polyuric syndrome)

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)

Urinary frequency

(2019): Shi FH+, Front Pharmacol Sep, 10:1066 [REVIEW]
(2014): Halimi S+, Diabetes Metab 40(6 Suppl 1), S28

Urinary tract infection

(2022): Tsai WC+, BMJ Open 12(10), e060655 [REVIEW] (increased risk)
(2022): Younes AM+, Int J Cardiol Jun, Online ahead of print [REVIEW]
(2021): Zheng C+, Cardiovasc Diabetol 20(1), 83 [REVIEW] (association)
(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)
(2018): Singh M+, Curr Drug Saf Feb, Epub ahead of print [REVIEW]
(2017): Trujillo JM+, Pharmacotherapy 37(4), 481
(2014): Halimi S+, Diabetes Metab 40(6 Suppl 1), S28
(2014): Mikhail N, World J Diabetes 5(6), 854 [REVIEW]
(2014): Nauck MA, Drug Des Devel Ther 8, 1335
(2013): Raskin P, Diabetes Metab Res Rev 29(5), 347 [REVIEW]
(2013): Vasilakou D+, Ann Intern Med 159(4), 262 [REVIEW]
Negative findings
(2024): Iordan L+, Medicina (Kaunas) 60(12), 1974

Vaginitis (includes vulvitis)

(2022): Mounsey SJ+, Int J Dermatol Oct, Online ahead of print (11 cases)

Polycythemia / erythrocytosis

(2025): Edahiro Y, Rinsho Ketsueki (Japanese) 66(4), 220-227
(2025): Tramontana F+, Endocr Connect Jun, Online ahead of print [REVIEW] (with testosterone)
(2021): Gangat N+, Blood 138(26), 2886-2889 (30 cases) (association)

Bone loss / bone disorder

(2018): Blau JE+, Nat Rev Nephrol 14(8), 473-474 (association)

Fractures

(2018): Singh M+, Curr Drug Saf Feb, Epub ahead of print [REVIEW]
(2017): Trujillo JM+, Pharmacotherapy 37(4), 481
(2016): Scheen AJ, Curr Diab Rep 16(10), 92 [REVIEW]

Glomerular filtration rate decreased

(2024): Günes-Altan M+, Cardiovasc Diabetol 23(1), 184

Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury

(2014): Mikhail N, World J Diabetes 5(6), 854 [REVIEW]

Renal function abnormal / renal dysfunction

(2019): Mirabelli M+, J Diabetes Res Nov (e-Collection)

Adverse effects / adverse reactions

(2023): Edwards S+, Sr Care Pharm 38(7), 276-287 [REVIEW]
(2023): Scheen AJ+, Diabetes Metab Jan, Online ahead of print [REVIEW]
(2023): Stöllberger C+, Expert Rev Cardiovasc Ther 21(11), 803-816 [REVIEW]
(2022): Davidson JA+, J Diabetes Investig Oct, Online ahead of print [REVIEW]
(2022): Mascolo A+, Front Cardiovasc Med Sep (e-Collection) [REVIEW]
(2022): Pollack R+, Heart Fail Clin 18(4), 635-643 [REVIEW]
(2021): Martínez-Vizcaíno V+, J Clin Med 10(12), 2713 [REVIEW]
(2021): Zhou X+, Front Pharmacol Dec (e-Collection)
(2020): Cai Y+, Expert Opin Drug Saf Sep, Online ahead of print [REVIEW] (with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers)
(2017): Raschi E+, Nutr Metab Cardiovasc Dis 27(12), 1098
Negative findings
(2025): Ha KH+, Diabetes Metab May, Online ahead of print (reduced risk of adverse cardiorenal outcomes)
(2025): Laborante R+, Eur J Intern Med Jan [REVIEW]
(2025): Shah SA+, Drugs Aging Feb, Online ahead of print [REVIEW]

Cancer

(2018): Singh M+, Curr Drug Saf Feb, Epub ahead of print [REVIEW]

Drugs belonging to restart save

class – Sodium-glucose co-transporter 2 (SGLT2) inhibitor ('gliflozin') – 4 items found

Adverse reactions attributed to entire drug class 'Sodium-glucose co-transporter 2 (SGLT2) inhibitor ('gliflozin')'

Litt's app available free to subscribers